Pharma-Bio Serv (PBSV) Expected to Announce Earnings on Monday

Pharma-Bio Serv (OTCMKTS:PBSV) is expected to be releasing its earnings data on Monday, January 27th. Analysts expect Pharma-Bio Serv to post earnings of $0.03 per share and revenue of $4,000.00 billion for the quarter.

Pharma-Bio Serv Stock Performance

Shares of PBSV opened at $0.58 on Friday. The stock has a 50 day moving average price of $0.53 and a 200 day moving average price of $0.58. Pharma-Bio Serv has a one year low of $0.31 and a one year high of $1.08. The stock has a market capitalization of $13.34 million, a price-to-earnings ratio of -19.37 and a beta of 0.51.

About Pharma-Bio Serv

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.